Stocktoria
Strata Critical Medical, Inc. SRTA
Nasdaq · stock · Services-Health Services · website · IPO 2019-09-17
Strata Critical Medical, Inc. financials (annual)
Bars are annual figures from 2019 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2020 | FY2019 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $197.1M | $146.8M | $225.2M | $146.1M | $50.5M | — | $23.4M | — | $31.2M |
| Gross profit | $41.1M | $29.6M | — | — | — | — | — | — | — |
| SG&A expense | $60.9M | $50.9M | — | — | — | — | — | — | — |
| Operating income | -$22.4M | -$22.5M | -$68.1M | -$53.5M | -$24.1M | -$678,487 | -$10.4M | — | -$11.5M |
| Income tax | $0 | $0 | -$1.5M | -$772,000 | -$3.6M | $210,465 | $0 | $208,612 | $0 |
| Net income | $41.3M | -$27.3M | -$56.1M | -$27.3M | -$40.1M | $127,718 | -$10.2M | — | -$10.8M |
| EPS (diluted) | $0.50 | $-0.35 | $-0.76 | $-0.38 | $-0.93 | — | $-0.40 | — | $-0.43 |
| Operating cash flow | -$48.9M | -$2.5M | -$32.3M | -$37.1M | -$15.6M | -$794,467 | -$10.8M | — | -$10.3M |
| Free cash flow | -$58.5M | -$33.4M | -$34.5M | -$37.9M | -$15.9M | — | -$11.2M | — | -$10.9M |
| Cash & equivalents | $31.0M | $18.4M | $27.9M | $41.3M | $7.0M | $846,068 | $12.2M | $1.3M | $22.2M |
| Total assets | $325.5M | $256.7M | $294.9M | $325.0M | $343.4M | $277.8M | $17.7M | $277.7M | $277.0M |
| Total liabilities | $46.4M | $34.7M | $60.6M | $50.5M | $52.2M | $46.8M | $6.6M | $10.0M | $10.0M |
| Shareholders' equity | $279.1M | $221.9M | $234.3M | $274.5M | $291.2M | $10.0M | $11.1M | $5.0M | $20.7M |
Growth · year-over-year · Revenue CAGR 36%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2020 | FY2019 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +34.3% | -34.8% | +54.1% | +189.2% | — | — | — | — | — |
| Net income growth | — | — | — | — | -31459.7% | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.